Myeloma Novel Drug Targets and agents
Activation of the FOXO3/GSDME axis to overcome bortezomib resistance for the treatment of myeloma via pyroptosis
Xinliang Mao, MD PhD (he/him/his)
Professor, Vice Director
Guangzhou Medical University
Guangzhou, United States